LCS 510(k) clearance sets stage for commercialization in the United States New leadership of U.S. subsidiary and collaboration with Tempus accelerate rollout 28% reduction in ...
Telix has delivered a string of radiopharmaceuticals greatest hits with more to come but there have also been some misses ...
Paradigm Capital initiates coverage on Western Exploration Western Exploration Inc. is pleased to announce results of an ALS-GoldSPOT geochemical-spectral analysis of drill core from the Jarbidge Vein ...
Background Patients who consult their GP about psychological complaints, such as feeling anxious or depressed, are often ...
Despite data gaps in many countries, the burden of sickle cell disease, especially in west and central Africa, underscores ...
Zacks Investment Research on MSN
Glaukos wins permanent J-code for Epioxa keratoconus therapy
Glaukos GKOS announced that its innovative keratoconus treatment, Epioxa (Epioxa HD / Epioxa), was assigned a permanent HCPCS ...
The authors updated a diagnosis list to identify low-acuity emergency department visits by veterans and applied it to examine ...
At the very beginning of the game, you find yourself in your cell with your Accessory. After a brief explination of what has happened in the story, being your sentence has being reset, you will then ...
Track Elin Electronics share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & ...
Track Vasa Denticity share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & ...
Objective Children and young people (CYP) with special educational needs (SENs) have an increased risk of psychopathology and ...
Third-Quarter Net Income of $0.9 million, or $0.07 per diluted share Q3 FY26 net sales increase led by a 9.7% YoY increase in PMT net sales Total backlog at February 28, 2026, was up 11.4% from end of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results